98 related articles for article (PubMed ID: 20045287)
1. Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei.
Jiang ZD; Ke S; Dupont HL
Int J Antimicrob Agents; 2010 Mar; 35(3):278-81. PubMed ID: 20045287
[TBL] [Abstract][Full Text] [Related]
2. Natural plant products inhibits growth and alters the swarming motility, biofilm formation, and expression of virulence genes in enteroaggregative and enterohemorrhagic Escherichia coli.
García-Heredia A; García S; Merino-Mascorro JÁ; Feng P; Heredia N
Food Microbiol; 2016 Oct; 59():124-32. PubMed ID: 27375253
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 response in an intestinal HCT-8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli.
Huang DB; DuPont HL; Jiang ZD; Carlin L; Okhuysen PC
Clin Diagn Lab Immunol; 2004 May; 11(3):548-51. PubMed ID: 15138180
[TBL] [Abstract][Full Text] [Related]
4. Elimination of a virulence plasmid from Shigella sonnei and Escherichia coli by antibiotics.
Michel-Briand Y; Laporte JM; Couetdic G; Sansonetti PJ
Ann Inst Pasteur Microbiol; 1986; 137B(3):291-5. PubMed ID: 3318870
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles.
Brown EL; Xue Q; Jiang ZD; Xu Y; Dupont HL
Antimicrob Agents Chemother; 2010 Jan; 54(1):388-96. PubMed ID: 19858255
[TBL] [Abstract][Full Text] [Related]
6. In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea.
Ruiz J; Mensa L; O'Callaghan C; Pons MJ; González A; Vila J; Gascón J
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):473-5. PubMed ID: 17889485
[TBL] [Abstract][Full Text] [Related]
7. Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability.
Ruiz J; Mensa L; Pons MJ; Vila J; Gascon J
J Antimicrob Chemother; 2008 May; 61(5):1016-9. PubMed ID: 18325895
[TBL] [Abstract][Full Text] [Related]
8. Rifaximin--a novel antimicrobial for enteric infections.
Huang DB; DuPont HL
J Infect; 2005 Feb; 50(2):97-106. PubMed ID: 15667909
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the periplasmic chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic Escherichia coli (ETEC) clinical isolates.
Nicklasson M; Sjöling A; Lebens M; Tobias J; Janzon A; Brive L; Svennerholm AM
Microb Pathog; 2008 Mar; 44(3):246-54. PubMed ID: 18037262
[TBL] [Abstract][Full Text] [Related]
10. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates.
Gomes C; Ruiz L; Pons MJ; Ochoa TJ; Ruiz J
Trans R Soc Trop Med Hyg; 2013 Sep; 107(9):545-9. PubMed ID: 23843564
[TBL] [Abstract][Full Text] [Related]
11. Natural and synthetic antimicrobials reduce adherence of enteroaggregative and enterohemorrhagic Escherichia coli to epithelial cells.
Ortiz Y; García-Heredia A; Merino-Mascorro A; García S; Solís-Soto L; Heredia N
PLoS One; 2021; 16(5):e0251096. PubMed ID: 33939753
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.
Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J
J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli as a pathogen in dogs and cats.
Beutin L
Vet Res; 1999; 30(2-3):285-98. PubMed ID: 10367359
[TBL] [Abstract][Full Text] [Related]
14. Travellers' diarrhoea: prospects for successful immunoprophylaxis.
Levine MM
Scand J Gastroenterol Suppl; 1983; 84():121-34. PubMed ID: 6138855
[TBL] [Abstract][Full Text] [Related]
15. Autotransporters and virulence of enteroaggregative E. coli.
Navarro-Garcia F; Elias WP
Gut Microbes; 2011; 2(1):13-24. PubMed ID: 21637014
[TBL] [Abstract][Full Text] [Related]
16. Relationship between enterotoxigenic Escherichia coli and diarrhea among children in Buenos Aires.
Binsztein N; Rivas M; López Moral L; Viboud G; Iriarte C; Szefner M; Svennerholm AM
Medicina (B Aires); 1992; 52(2):103-8. PubMed ID: 1308901
[TBL] [Abstract][Full Text] [Related]
17. Enteroinvasive Escherichia coli vs. Shigella flexneri: how different patterns of gene expression affect virulence.
Moreno AC; Ferreira LG; Martinez MB
FEMS Microbiol Lett; 2009 Dec; 301(2):156-63. PubMed ID: 19889166
[TBL] [Abstract][Full Text] [Related]
18. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.
Parsot C
FEMS Microbiol Lett; 2005 Nov; 252(1):11-8. PubMed ID: 16182469
[TBL] [Abstract][Full Text] [Related]
19. Beyond serotypes and virulence-associated factors: detection of genetic diversity among O153:H45 CFA/I heat-stable enterotoxigenic Escherichia coli strains.
Pacheco AB; Ferreira LC; Pichel MG; Almeida DF; Binsztein N; Viboud GI
J Clin Microbiol; 2001 Dec; 39(12):4500-5. PubMed ID: 11724869
[TBL] [Abstract][Full Text] [Related]
20. Bile acids improve the antimicrobial effect of rifaximin.
Darkoh C; Lichtenberger LM; Ajami N; Dial EJ; Jiang ZD; DuPont HL
Antimicrob Agents Chemother; 2010 Sep; 54(9):3618-24. PubMed ID: 20547807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
